Peptide Characterization

Introduction: Setting a therapeutic peptide API purity specification is one of the most consequential — and most frequently misjudged — […]

Introduction The structural characterization of biomolecular assemblies increasingly depends on Native Mass Spectrometry for Therapeutic Peptide Characterization, as it enables

Introduction: Peptide therapeutics are one of the fastest-growing drug classes in the pharmaceutical pipeline, but their structural complexity demands rigorous

Introduction Peptide physicochemical characterization services establish the scientific basis required to confirm the molecular identity, therapeutic suitability, and regulatory compliance

Introduction: Advanced Advancements in Peptide Impurity Identification and Characterization Services Peptide Impurity Identification and Characterization Services are specialized analytical solutions

Multi-Attribute Monitoring (MAM) for Therapeutic Peptide Characterization: A Modern LC-MS Workflow Introduction Liquid chromatography-mass spectrometry (LC-MS)-based Multi-Attribute Monitoring (MAM) has

Introduction: The landscape of incretin-based therapies has expanded far beyond the first-generation GLP-1 receptor agonists. Regulatory submissions for GLP-2 and

Modern Analytical Platforms for Peptide Mapping and Sequence Analysis This section explains how high-resolution mass spectrometry combined with liquid chromatography

Introduction: Disulfide Bond Mapping of Cyclic Peptides is one of the most technically demanding — and most heavily scrutinized —

Introduction: Why Demonstrating Peptide Sameness Is Analytically Challenging Establishing “sameness” for a traditional small-molecule generic drug generally involves confirming chemical